Drug Screening Platforms and RPPA
Author:
Publisher
Springer Singapore
Link
http://link.springer.com/content/pdf/10.1007/978-981-32-9755-5_11
Reference59 articles.
1. Accordi B, Espina V, Giordan M, VanMeter A, Milani G, Galla L, Ruzzene M, Sciro M, Trentin L, De Maria R, te Kronnie G, Petricoin E, Liotta L, Basso G (2010) Functional protein network activation mapping reveals new potential molecular drug targets for poor prognosis pediatric BCP-ALL. PLoS One 5(10):e13552. https://doi.org/10.1371/journal.pone.0013552
2. Ahern TP, Pedersen L, Tarp M, Cronin-Fenton DP, Garne JP, Silliman RA, Sorensen HT, Lash TL (2011) Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study. J Natl Cancer Inst 103(19):1461–1468. https://doi.org/10.1093/jnci/djr291
3. Akbani R, Becker KF, Carragher N, Goldstein T, de Koning L, Korf U, Liotta L, Mills GB, Nishizuka SS, Pawlak M, Petricoin EF 3rd, Pollard HB, Serrels B, Zhu J (2014) Realizing the promise of reverse phase protein arrays for clinical, translational, and basic research: a workshop report: the RPPA (reverse phase protein Array) society. Mol Cell Proteomics 13(7):1625–1643. https://doi.org/10.1074/mcp.O113.034918
4. Al-Lazikani B, Banerji U, Workman P (2012) Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol 30(7):679–692. https://doi.org/10.1038/nbt.2284
5. Bailey HH, Mahoney MR, Ettinger DS, Maples WJ, Fracasso PM, Traynor AM, Erlichman C, Okuno SH (2006) Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma. Cancer 107(10):2462–2467. https://doi.org/10.1002/cncr.22308
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Profiling histone posttranslational modifications and chromatin-modifying proteins by high-throughput reverse phase protein array;Epigenetics in Human Disease;2024
2. Identification of DOT1L inhibitor in a screen for factors that promote dopaminergic neuron survival;Frontiers in Aging Neuroscience;2022-12-12
3. Identification of DOT1L Inhibitor in a Screen for Factors that Promote Dopaminergic Neuron Survival;2022-08-25
4. High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array;Journal of Proteomics;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3